Accentia Biopharmaceuticals Inc.

Accentia Biopharmaceuticals, Inc., a biopharmaceutical company, together with its subsidiaries, develops and commercializes drug candidates that are in late-stage clinical development based on active pharmaceutical ingredients in the therapeutic areas of respiratory disease and oncology. It operates in two segments: Biopharmaceutical Products and Services, and Specialty Pharmaceuticals. The Biopharmaceutical Products and Services segment develops late-stage biopharmaceutical products. The Specialty Pharmaceuticals segment markets and sells pharmaceutical products that are developed primarily by third-party development partners.

Acquired Companies: TEAMM Pharmaceuticals Inc., Biovest International Inc., Analytica International, Inc.
API Development Stage

API Services

API Types